Telomir Pharmaceuticals, Inc.
TELONasdaqCIK 1971532HealthcareFiscal year ends Dec 31
Reports and events: 80 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-05-1507:45 ET | 8-K | 8.01 Other events | 0001641172-25-010518 |
| 2025-05-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010298 |
| 2025-05-0707:30 ET | 8-K | 8.01 Other events | 0001641172-25-008956 |
| 2025-03-1907:30 ET | 8-K | 8.01 Other events | 0001493152-25-010868 |
| 2025-02-2516:01 ET | 8-K | 8.01 Other events | 0001493152-25-008195 |
| 2025-02-2016:01 ET | 8-K | 8.01 Other events | 0001493152-25-007698 |
| 2025-02-1807:30 ET | 8-K | 8.01 Other events | 0001493152-25-007080 |
| 2025-02-0416:45 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-004872 |
| 2025-01-2807:30 ET | 8-K | 8.01 Other events | 0001493152-25-003909 |
| 2025-01-0707:30 ET | 8-K | 8.01 Other events | 0001493152-25-001112 |
| 2024-12-2307:00 ET | 8-K | 8.01 Other events | 0001493152-24-051191 |
| 2024-12-2017:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-051090 |
| 2024-12-1116:01 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-24-049630 |
| 2024-12-0216:01 ET | 8-K | 8.01 Other events | 0001493152-24-048285 |
| 2024-11-2116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-047145 |
| 2024-11-2016:15 ET | 8-K | 8.01 Other events | 0001493152-24-046982 |
| 2024-11-1216:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044749 |
| 2024-09-2716:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-038530 |
| 2024-09-0316:37 ET | 8-K | 8.01 Other events | 0001493152-24-034831 |
| 2024-08-1316:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031606 |
| 2024-06-2417:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-024812 |
| 2024-05-1316:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018909 |
| 2024-04-1516:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-014616 |
| 2024-04-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-014446 |
| 2024-03-2917:28 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-012049 |
| 2024-02-1316:27 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-006094 |
| 2024-01-0310:50 ET | S-1/A | Registration statement, amended | 0001493152-24-000217 |
| 2023-12-1917:19 ET | S-1/A | Registration statement, amended | 0001493152-23-045454 |
| 2023-12-1417:09 ET | S-1/A | Registration statement, amended | 0001493152-23-044902 |
| 2023-11-1421:36 ET | S-1 | Registration statement | 0001493152-23-040696 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.